Cellectis S.A. (NASDAQ: CLLS) had its price target lowered by analysts at Barclays PLC from $9.00 to $7.00.
Cellectis S.A. - American Depositary Shares (CLLS)
Last cellectis s.a. - american depositary shares earnings: 3/4 04:30 pm
Check Earnings Report
US:NASDAQ Investor Relations:
cellectis.com/en/investors
Company Research
Source: MarketBeat
Impact Snapshot
Event Time:
CLLS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CLLS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CLLS alerts
High impacting Cellectis S.A. - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
CLLS
News
- Cellectis S.A. (<a href="https://www.marketbeat.com/stocks/NASDAQ/CLLS/price-target/">NASDAQ: CLLS</a>) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $4.00 price target on tMarketBeat
- Cellectis S.A. (<a href="https://www.marketbeat.com/stocks/NASDAQ/CLLS/price-target/">NASDAQ: CLLS</a>) was upgraded by analysts at Robert W. Baird from a "neutral" rating to an "outperform" rating. They now have a $10.00 price target onMarketBeat
- Cellectis S.A. (<a href="https://www.marketbeat.com/stocks/NASDAQ/CLLS/price-target/">NASDAQ: CLLS</a>) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.MarketBeat
- Cellectis Presents Research Data On A Novel Immune-Evasive Universal CAR T-cell At ASGCT [TheStreet.com]TheStreet.com
- Cellectis Presents Research Data on a Novel Immune-Evasive Universal CAR T-cell at ASGCTGlobeNewswire
CLLS
Earnings
- 5/12/22 - Miss
CLLS
Sec Filings
- 5/16/22 - Form 6-K
- 5/12/22 - Form 6-K
- 5/12/22 - Form 6-K
- CLLS's page on the SEC website